Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 & 2, Randomized Open-Label Study to Evaluate the Pharmacokinetics, Safety and Antiretroviral Activity of Succinylated Human Serum Albumin (Suc-HSA) in Treatment Naïve HIV-1 Infected Subjects

NCT00128063 is registered in ClinicalTrials.gov with International Antiviral Therapy Evaluation Center as lead sponsor.

NCT NCT00128063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00128063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 & 2, Randomized Open-Label Study to Evaluate the Pharmacokinetics, Safety and Antiretroviral Activity of Succinylated Human Serum Albumin (Suc-HSA) in Treatment Naïve HIV-1 Infected Subjects
Lead sponsor
International Antiviral Therapy Evaluation Center
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2005
Completion date
June 30, 2006
Enrollment
6
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections